News

Colon cancer​ patients saw improved survival rates after a 3-year exercise program, according to a first-of-its-kind ...
The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...
Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.
New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...
Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...
Eating white bread and other foods considered to be proinflammatory can raise colon cancer patients’ risk of death from the ...
AstraZeneca Plc (NASDAQ:AZN) on Monday released results from three Phase 3 clinical trials at the 2025 American Society of ...
The Trump administration's proposed funding cuts to the National Institutes of Health (NIH), including the National Cancer ...
Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer survival disparities among racial and ethnic subgroups, particularly ...
Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer ...
With the American Society of Clinical Oncology (ASCO) annual meeting in full swing at Chicago’s McCormick Place this past ...
Oncology biosimilars significantly reduce financial toxicity in cancer care, as highlighted in 2 abstracts presented at the ...